CPMV Mosaic ImmunoEngineering Inc.
Biological Products, (No Diagnostic Substances) · OTC · SEC CIK 836564 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY0.8%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-2,254.4%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets238,930.6%
Debt / equity—
Current ratio0.00x
Interest coverage-60.40x
Cash quality & payout
Operating cash flow / net income0.08x
Accruals ratio-2,078.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $63,981 | $183,867 |
| SG&A expense | $552,138 | $695,788 |
| Operating income | -$616,119 | -$879,655 |
| Interest expense | $10,001 | $6,954 |
| Pretax income | -$685,446 | -$919,583 |
| Income tax | $2,400 | $2,400 |
| Net income | -$687,846 | -$921,983 |
| EPS (basic) | -0.10 | -0.13 |
| EPS (diluted) | -0.10 | -0.13 |
| Weighted avg. shares (diluted) | — | 7.24M |
| Balance sheet | ||
| Cash & equivalents | $3,622 | $115,019 |
| Current assets | $19,882 | $141,611 |
| Total assets | $19,882 | $141,611 |
| Current liabilities | $6.03M | $5.54M |
| Total liabilities | $7.50M | $6.93M |
| Shareholders' equity | -$7.48M | -$6.79M |
| Shares outstanding | 7.24M | 7.24M |
| Cash flow statement | ||
| Operating cash flow | -$111,397 | -$241,159 |
| Investing cash flow | — | $0 |
| Financing cash flow | $0 | $200,000 |
| Stock-based compensation | $0 | $4,867 |
Free plan shows the latest 2 periods; Pro shows all 15 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.